Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Detalles Bibliográficos
Autores principales: Gantenbein, Andreas R., Agosti, Reto, Kamm, Christian P., Landmann, Gunther, Meier, Niklaus, Merki-Feld, Gabriele Susanne, Petersen, Jens A., Pohl, Heiko, Ryvlin, Philippe, Schankin, Christoph J., Viceic, Dragana, Zecca, Chiara, Schäfer, Elisabeth, Meyer, Ina, Arzt, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764682/
https://www.ncbi.nlm.nih.gov/pubmed/36536271
http://dx.doi.org/10.1186/s10194-022-01530-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764682/
https://www.ncbi.nlm.nih.gov/pubmed/36536271
http://dx.doi.org/10.1186/s10194-022-01530-9

Ejemplares similares